Home / Inspections / 1277181

FDA Inspection 1277181 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 3004829714

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on June 24, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Philadelphia, PA (United States)

Facility

Other inspections at this facility

  • 1175133 (VAI Fri Jul 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1060670 (VAI Wed Jun 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940375 (VAI Wed May 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846805 (VAI Wed May 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 747381 (VAI Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources